p53 Involvement in the control of murine hair follicle regression.

PubWeight™: 1.19‹?› | Rank: Top 10%

🔗 View Article (PMC 1891974)

Published in Am J Pathol on June 01, 2001

Authors

V A Botchkarev1, E A Komarova, F Siebenhaar, N V Botchkareva, A A Sharov, P G Komarov, M Maurer, A V Gudkov, B A Gilchrest

Author Affiliations

1: Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts 02118, USA. vladbotc@bu.edu

Articles citing this

Pathologies associated with the p53 response. Cold Spring Harb Perspect Biol (2010) 1.40

Mechanisms involved in injury and repair of the murine lacrimal gland: role of programmed cell death and mesenchymal stem cells. Ocul Surf (2010) 1.08

Disruption of the hedgehog signaling pathway contributes to the hair follicle cycling deficiency in Vdr knockout mice. J Cell Physiol (2010) 1.05

p53/p63/p73 in the epidermis in health and disease. Cold Spring Harb Perspect Med (2014) 1.01

Involvement of the Edar signaling in the control of hair follicle involution (catagen). Am J Pathol (2006) 1.01

Matrix metalloproteinase-9 is involved in the regulation of hair canal formation. J Invest Dermatol (2010) 0.88

Influence of FHIT on benzo[a]pyrene-induced tumors and alopecia in mice: chemoprevention by budesonide and N-acetylcysteine. Proc Natl Acad Sci U S A (2006) 0.86

Post-transcriptional Regulation of Keratinocyte Progenitor Cell Expansion, Differentiation and Hair Follicle Regression by miR-22. PLoS Genet (2015) 0.83

Beneficial effects of Astragaloside IV for hair loss via inhibition of Fas/Fas L-mediated apoptotic signaling. PLoS One (2014) 0.83

Mouse models for human hair loss disorders. J Anat (2003) 0.83

Akt2 and SGK3 are both determinants of postnatal hair follicle development. FASEB J (2009) 0.83

A multi-scale model for hair follicles reveals heterogeneous domains driving rapid spatiotemporal hair growth patterning. Elife (2017) 0.82

Modifying radiation damage. Curr Drug Targets (2010) 0.81

Pygo2 regulates β-catenin-induced activation of hair follicle stem/progenitor cells and skin hyperplasia. Proc Natl Acad Sci U S A (2014) 0.79

A functional role of RB-dependent pathway in the control of quiescence in adult epidermal stem cells revealed by genomic profiling. Stem Cell Rev (2010) 0.78

Hair-cycle dependent differential expression of ADAM 10 and ADAM 12: An immunohistochemical analysis in human hair follicles in situ. Dermatoendocrinol (2009) 0.76

Protective effect of Korean Red Ginseng against chemotherapeutic drug-induced premature catagen development assessed with human hair follicle organ culture model. J Ginseng Res (2015) 0.75

Mechanism of apoptotic regulation of follicular regression: toward understanding the molecular basis for tissue remodeling and regeneration. Am J Pathol (2001) 0.75

The tissue dependent interactions between p53 and Bcl-2 in vivo. Oncotarget (2015) 0.75

DNA Polymorphism of Insulin-like Growth Factor-binding Protein-3 Gene and Its Association with Cashmere Traits in Cashmere Goats. Asian-Australas J Anim Sci (2012) 0.75

p53 activity contributes to defective interfollicular epidermal differentiation in hyperproliferative murine skin. Br J Dermatol (2015) 0.75

Articles cited by this

p53, the cellular gatekeeper for growth and division. Cell (1997) 31.04

Tumor spectrum analysis in p53-mutant mice. Curr Biol (1994) 16.60

Participation of p53 protein in the cellular response to DNA damage. Cancer Res (1991) 16.00

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell (1995) 14.90

The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev (1998) 7.46

A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science (1999) 6.97

Controls of hair follicle cycling. Physiol Rev (2001) 5.49

The biology of hair follicles. N Engl J Med (1999) 4.46

Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature (1995) 3.55

Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res (1994) 3.02

Noggin is a mesenchymally derived stimulator of hair-follicle induction. Nat Cell Biol (1999) 2.99

A comprehensive guide for the recognition and classification of distinct stages of hair follicle morphogenesis. J Invest Dermatol (1999) 2.92

Keratinocyte growth factor is required for hair development but not for wound healing. Genes Dev (1996) 2.82

Growth of the hair. Physiol Rev (1954) 2.77

Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest (1997) 2.32

The cellular response to p53: the decision between life and death. Oncogene (1999) 2.31

Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene. Proc Natl Acad Sci U S A (1996) 2.09

Analysis of apoptosis during hair follicle regression (catagen) Am J Pathol (1997) 1.82

Growth and differentiation of hair follicles between periods of activity and quiescence. J Exp Zool (1961) 1.75

Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal. EMBO J (1994) 1.64

Telogen skin contains an inhibitor of hair growth. Br J Dermatol (1990) 1.64

SCF/c-kit signaling is required for cyclic regeneration of the hair pigmentation unit. FASEB J (2001) 1.54

Control of murine hair follicle regression (catagen) by TGF-beta1 in vivo. FASEB J (2000) 1.48

p53 is essential for developmental neuron death as regulated by the TrkA and p75 neurotrophin receptors. J Cell Biol (1998) 1.36

The influence of the hair cycle on the thickness of mouse skin. Anat Rec (1984) 1.35

Alkaline phosphatase activity and localization during the murine hair cycle. Br J Dermatol (1994) 1.34

Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone. Am J Pathol (1994) 1.30

p53 is essential for chemotherapy-induced hair loss. Cancer Res (2000) 1.29

Effects of insulin and insulin-like growth factors on cultured human hair follicles: IGF-I at physiologic concentrations is an important regulator of hair follicle growth in vitro. J Invest Dermatol (1994) 1.27

Involvement of hepatocyte growth factor/scatter factor and met receptor signaling in hair follicle morphogenesis and cycling. FASEB J (2000) 1.26

Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia. Am J Pathol (1997) 1.17

The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal. Mol Cell Biol (1997) 1.15

The role of IGF-I in human skin and its appendages: morphogen as well as mitogen? J Invest Dermatol (1997) 1.12

Morphogenesis of the hair follicle during catagen. Z Zellforsch Mikrosk Anat (1970) 1.11

Topical calcitriol enhances normal hair regrowth but does not prevent chemotherapy-induced alopecia in mice. Cancer Res (1996) 1.02

Changes in expression of apoptosis-associated genes in skin mark early catagen. J Invest Dermatol (1995) 1.01

Different responses of epidermal and hair follicular cells to radiation correlate with distinct patterns of p53 and p21 induction. Am J Pathol (1999) 1.00

A role for p75 neurotrophin receptor in the control of apoptosis-driven hair follicle regression. FASEB J (2000) 0.98

The hair follicle: dying for attention. Am J Pathol (1997) 0.97

A new role for neurotrophin-3: involvement in the regulation of hair follicle regression (catagen). Am J Pathol (1998) 0.94

A new role for neurotrophins: involvement of brain-derived neurotrophic factor and neurotrophin-4 in hair cycle control. FASEB J (1999) 0.93

p53 facilitates pRb cleavage in IL-3-deprived cells: novel pro-apoptotic activity of p53. EMBO J (1998) 0.90

Dermal papilla cells derived from beard hair follicles secrete more stem cell factor (SCF) in culture than scalp cells or dermal fibroblasts. Biochem Biophys Res Commun (1996) 0.86

Immunohistochemical analysis of tissue remodelling during the anagen-catagen transition of the human hair follicle. Br J Dermatol (1997) 0.85

Dermal papilla cells express hepatocyte growth factor. J Dermatol Sci (1994) 0.81

Molecular characterization of the mouse Fas ligand promoter in airway epithelial cells. Biochim Biophys Acta (2000) 0.78

Articles by these authors

A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science (1999) 6.97

Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature (2000) 5.86

EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy (2009) 4.10

EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy (2009) 3.86

CENP-C, an autoantigen in scleroderma, is a component of the human inner kinetochore plate. Cell (1992) 3.70

The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy (2014) 3.10

Noggin is a mesenchymally derived stimulator of hair-follicle induction. Nat Cell Biol (1999) 2.99

A comprehensive guide for the recognition and classification of distinct stages of hair follicle morphogenesis. J Invest Dermatol (1999) 2.92

The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control. Nature (1998) 2.86

Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains. Proc Natl Acad Sci U S A (1996) 2.66

Treatment of children with port-wine stains using the flashlamp-pulsed tunable dye laser. N Engl J Med (1989) 2.30

Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17

Home versus hospital deliveries: follow up study of matched pairs for procedures and outcome. Zurich Study Team. BMJ (1996) 2.10

Relief of uremic pruritus with ultraviolet phototherapy. N Engl J Med (1977) 2.06

Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo. EMBO J (1997) 1.96

Noggin is required for induction of the hair follicle growth phase in postnatal skin. FASEB J (2001) 1.95

Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53. Oncogene (2001) 1.95

Photoageing: mechanism, prevention and therapy. Br J Dermatol (2007) 1.94

Mast cells as sentinels of innate immunity. Curr Opin Immunol (1999) 1.85

Factors responsible for differences between asymptomatic subjects and patients presenting an IgE sensitization to allergens. A GA2LEN project. Allergy (2006) 1.84

Mast cells can secrete vascular permeability factor/ vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of fc epsilon receptor I expression. J Exp Med (1998) 1.84

Analysis of apoptosis during hair follicle regression (catagen) Am J Pathol (1997) 1.82

Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature (1997) 1.78

Human melanogenesis is stimulated by diacylglycerol. J Invest Dermatol (1989) 1.71

Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer's disease. J Clin Invest (1997) 1.66

EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria. Allergy (2009) 1.65

Autologous whole blood injections to patients with chronic urticaria and a positive autologous serum skin test: a placebo-controlled trial. Dermatology (2006) 1.65

Photoaging/photodamage and photoprotection. J Am Acad Dermatol (1990) 1.63

E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro. J Cell Sci (1994) 1.59

c-Myc depletion inhibits proliferation of human tumor cells at various stages of the cell cycle. Oncogene (2007) 1.59

Molecular cloning, chromosome mapping and characterization of UBQLN3 a testis-specific gene that contains an ubiquitin-like domain. Gene (2000) 1.57

How to assess disease activity in patients with chronic urticaria? Allergy (2008) 1.55

EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy (2006) 1.55

SCF/c-kit signaling is required for cyclic regeneration of the hair pigmentation unit. FASEB J (2001) 1.54

Embolization of biologic glue during repair of aortic dissection. Ann Thorac Surg (1995) 1.52

Topically applied diacylglycerols increase pigmentation in guinea pig skin. J Invest Dermatol (1995) 1.52

Effect of aging and habitual sun exposure on the genetic response of cultured human keratinocytes to solar-simulated irradiation. J Invest Dermatol (1992) 1.52

How best to fight that nasty itch - from new insights into the neuroimmunological, neuroendocrine, and neurophysiological bases of pruritus to novel therapeutic approaches. Exp Dermatol (2005) 1.51

Control of murine hair follicle regression (catagen) by TGF-beta1 in vivo. FASEB J (2000) 1.48

DNA damage enhances melanogenesis. Proc Natl Acad Sci U S A (1996) 1.48

A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist. Proc Natl Acad Sci U S A (2001) 1.43

Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper. Allergy (2010) 1.42

Fatal recurrent subarachnoid hemorrhage after complete endovascular aneurysm occlusion. AJNR Am J Neuroradiol (2006) 1.40

Stress-induced secretion of growth inhibitors: a novel tumor suppressor function of p53. Oncogene (1998) 1.40

The definition and diagnostic testing of physical and cholinergic urticarias--EAACI/GA2LEN/EDF/UNEV consensus panel recommendations. Allergy (2009) 1.39

Poliovirus protein 3A inhibits tumor necrosis factor (TNF)-induced apoptosis by eliminating the TNF receptor from the cell surface. J Virol (2001) 1.39

The role of the hairless (hr) gene in the regulation of hair follicle catagen transformation. Am J Pathol (1999) 1.38

Cellular mechanisms regulating human melanogenesis. Cell Mol Life Sci (2009) 1.38

Abundant production of brain-derived neurotrophic factor by adult visceral epithelia. Implications for paracrine and target-derived Neurotrophic functions. Am J Pathol (1999) 1.37

Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway. Proc Natl Acad Sci U S A (2008) 1.36

Functional analysis and intracellular localization of p53 modified by SUMO-1. Oncogene (2001) 1.36

Different impact of p53 and p21 on the radiation response of mouse tissues. Oncogene (2000) 1.35

Schnitzler's syndrome: diagnosis, treatment, and follow-up. Allergy (2013) 1.35

Enhancement of DNA repair in human skin cells by thymidine dinucleotides: evidence for a p53-mediated mammalian SOS response. Proc Natl Acad Sci U S A (1997) 1.33

Oral methoxsalen photochemotherapy of mycosis fungoides. Cancer (1976) 1.33

NMR solution structure of a complex of calmodulin with a binding peptide of the Ca2+ pump. Biochemistry (1999) 1.33

Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53. Genes Dev (1998) 1.31

Differential association of products of alternative transcripts of the candidate tumor suppressor ING1 with the mSin3/HDAC1 transcriptional corepressor complex. J Biol Chem (2000) 1.31

Mechanisms and implications of the age-associated decrease in DNA repair capacity. FASEB J (2000) 1.30

p53 is essential for chemotherapy-induced hair loss. Cancer Res (2000) 1.29

Ultraviolet radiation directly induces pigment production by cultured human melanocytes. J Cell Physiol (1987) 1.28

EAACI/GA2LEN/EDF guideline: management of urticaria. Allergy (2006) 1.28

Melanogenesis during the anagen-catagen-telogen transformation of the murine hair cycle. J Invest Dermatol (1994) 1.27

Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors. Cancer Res (1993) 1.27

A simultaneous (15)N, (1)H- and (13)C, (1)H-HSQC with sensitivity enhancement and a heteronuclear gradient echo. J Biomol NMR (1995) 1.25

DNA damage and melanogenesis. Nature (1994) 1.25

Impaired mast cell development and innate immunity in Mac-1 (CD11b/CD18, CR3)-deficient mice. J Immunol (1998) 1.25

Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity. Br J Dermatol (2006) 1.24

9-Aminoacridine-based anticancer drugs target the PI3K/AKT/mTOR, NF-kappaB and p53 pathways. Oncogene (2009) 1.24

p53 modulation of anchorage independent growth and experimental metastasis. Oncogene (1996) 1.23

Forward genetics in mammalian cells: functional approaches to gene discovery. Hum Mol Genet (1999) 1.22

Characterization of functional vanilloid receptors expressed by mast cells. Blood (1998) 1.21

The human sunburn reaction: histologic and biochemical studies. J Am Acad Dermatol (1981) 1.20

Mycoplasma infection suppresses p53, activates NF-kappaB and cooperates with oncogenic Ras in rodent fibroblast transformation. Oncogene (2008) 1.20

Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria. Allergy (2014) 1.16

Re-engineering the toilet for sustainable waste water management. Environ Sci Technol (2001) 1.14

Selective cultivation of human melanocytes from newborn and adult epidermis. J Invest Dermatol (1984) 1.14

Rupatadine in allergic rhinitis and chronic urticaria. Allergy (2008) 1.13

Epidemiology of urticaria: a representative cross-sectional population survey. Clin Exp Dermatol (2010) 1.12

Structure and regulation of the mouse ing1 gene. Three alternative transcripts encode two phd finger proteins that have opposite effects on p53 function. J Biol Chem (1999) 1.12

Regulation of human melanocyte growth, dendricity, and melanization by keratinocyte derived factors. J Invest Dermatol (1989) 1.12

Increased concentrations of arachidonic acid, prostaglandins E2, D2, and 6-oxo-F1 alpha, and histamine in human skin following UVA irradiation. J Invest Dermatol (1983) 1.12

Antibacterial effects of cefroxadine, cephalexin and cephradine in a new in vitro pharmacokinetic model. J Antibiot (Tokyo) (1982) 1.11

Growth of human keratinocytes on fibronectin -coated plates. Cell Biol Int Rep (1980) 1.10

Up-dosing with bilastine results in improved effectiveness in cold contact urticaria. Allergy (2013) 1.09

Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica. J Neurol Neurosurg Psychiatry (2008) 1.08

Applications of green fluorescent protein as a marker of retroviral vectors. Somat Cell Mol Genet (1997) 1.08

The German version of the Chronic Urticaria Quality-of-Life Questionnaire: factor analysis, validation, and initial clinical findings. Allergy (2009) 1.07